AURA (Aura Biosciences) Other Financing: $0.00 Mil (TTM As of Mar. 2026)


AURA Aura Biosciences Inc AURA
34 GF Score
Price $6.84
! 3 Warning Signs
View Full Analysis

What is Aura Biosciences Other Financing?

Aura Biosciences AURA -2.15% 34 Other Financing is $0.00 Mil as of Mar. 2026. GuruFocus rates AURA with a GF Score™ of 34/100. The stock has 3 warning signs investors should review.

Aura Biosciences's Other Financing for the three months ended in Mar. 2026 was $0.00 Mil.

Aura Biosciences's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was $0.00 Mil.

Aura Biosciences Other Financing Historical Data

* Premium members only.

The historical data trend for Aura Biosciences's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aura Biosciences Other Financing Chart

Aura Biosciences Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial 0.33 0.43 -91.11 0.00 24.58

Aura Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
AURA
34GF Score
Aura Biosciences Inc AURA
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aura Biosciences Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $0.00 Mil mean?
Aura Biosciences (AURA) has a Other Financing of $0.00 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Aura Biosciences and its competitors.
Is Aura Biosciences' Other Financing too high?
Aura Biosciences' current Other Financing is $0.00 Mil. Overall, Aura Biosciences has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Aura Biosciences' Other Financing compare to NVCT and CADL?
Aura Biosciences' Other Financing of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Biotechnology company?
A good Other Financing depends on the Biotechnology industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Aura Biosciences and its competitors. Aura Biosciences's current Other Financing is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aura Biosciences stock overvalued right now?
Aura Biosciences (AURA) has a current Other Financing of $0.00 Mil. The current Other Financing is $0.00 Mil. Aura Biosciences' overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Aura Biosciences (AURA), the current Other Financing is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aura Biosciences Business Description

Address 80 Guest Street, Boston, MA, USA, 02135
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
34GF Score

Get the complete analysis for AURA

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.84
Price